Abstract
BackgroundPatients with autoimmune rheumatic diseases are at higher risk of cardiovascular complications and premature mortality[1,2], possibly related to chronic inflammation. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have